Share
Julie Manchester
Autonomix Medical, Inc., a pioneering medical device company focused on transforming the diagnosis and treatment of nervous system-related diseases, has appointed Julie Manchester as its new Vice President of Regulatory Affairs and Quality.
This strategic hire comes as the Company moves forward with its clinical and regulatory roadmap, following the successful completion of animal testing and design lock for its proprietary radiofrequency (RF) technology.
Autonomix is actively strengthening its leadership team and infrastructure to support upcoming regulatory milestones, including the submission of an Investigational Device Exemption (IDE) and the launch of a pivotal clinical trial in 2025 aimed at supporting a De Novo FDA submission.
Ms. Manchester brings over 15 years of leadership experience in regulatory affairs and quality management across the medical device, cosmetics, pharmaceutical, and product testing sectors. She has successfully developed and overseen regulatory strategies, quality systems, and global product launches.
Her expertise includes managing multi-site operations - including international locations - while driving compliance and operational excellence. Her proven ability to build and scale high-performing teams will be instrumental in guiding Autonomix through its next phase of growth and regulatory execution.
Related posts
